265 related articles for article (PubMed ID: 38046909)
1. Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder.
Patel RN; Sharma A; Prasad A; Bansal S
Kidney Med; 2023 Dec; 5(12):100705. PubMed ID: 38046909
[TBL] [Abstract][Full Text] [Related]
2. Interrelation between heart failure with preserved ejection fraction and renal impairment.
Joslin JR; Lioudaki E; Androulakis E
Rev Cardiovasc Med; 2022 Feb; 23(2):69. PubMed ID: 35229560
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients.
Mark PB; Mangion K; Rankin AJ; Rutherford E; Lang NN; Petrie MC; Stoumpos S; Patel RK
Clin Kidney J; 2022 Dec; 15(12):2186-2199. PubMed ID: 36381379
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Management of Patients With Kidney Disease and Heart Failure With Preserved Ejection Fraction.
Tuttle ML; Fang JC; Sarnak MJ; McCallum W
Semin Nephrol; 2024 May; ():151516. PubMed ID: 38704338
[TBL] [Abstract][Full Text] [Related]
5. Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction-A Specific HFpEF Phenotype.
Elsanhoury A; Nelki V; Kelle S; Van Linthout S; Tschöpe C
Front Cardiovasc Med; 2021; 8():720690. PubMed ID: 34604353
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Heart Failure with Preserved Ejection Fraction.
Ilieșiu AM; Hodorogea AS
Adv Exp Med Biol; 2018; 1067():67-87. PubMed ID: 29498023
[TBL] [Abstract][Full Text] [Related]
7. A Review of Sodium-Glucose Cotransporter 2 Inhibitor's Clinical Efficacy in Heart Failure With Preserved Ejection Fraction.
Epperson J; Athar ZM; Arshad M; Chen E
Cureus; 2024 Apr; 16(4):e57380. PubMed ID: 38694659
[TBL] [Abstract][Full Text] [Related]
8. Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
Belli M; Barone L; Bellia A; Sergi D; Lecis D; Prandi FR; Milite M; Galluccio C; Muscoli S; Romeo F; Barillà F
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498924
[TBL] [Abstract][Full Text] [Related]
9. Emerging Horizons in Heart Failure with Preserved Ejection Fraction: The Role of SGLT2 Inhibitors.
Heath R; Johnsen H; Strain WD; Evans M
Diabetes Ther; 2022 Feb; 13(2):241-250. PubMed ID: 35084695
[TBL] [Abstract][Full Text] [Related]
10. Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon.
Lucà F; Oliva F; Abrignani MG; Di Fusco SA; Gori M; Giubilato S; Ceravolo R; Temporelli PL; Cornara S; Rao CM; Caretta G; Pozzi A; Binaghi G; Maloberti A; Di Nora C; Di Matteo I; Pilleri A; Gelsomino S; Riccio C; Grimaldi M; Colivicchi F; Gulizia MM
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592244
[TBL] [Abstract][Full Text] [Related]
11. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
Packer M
J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
[TBL] [Abstract][Full Text] [Related]
12. Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists.
Cimino G; Vaduganathan M; Lombardi CM; Pagnesi M; Vizzardi E; Tomasoni D; Adamo M; Metra M; Inciardi RM
ESC Heart Fail; 2024 Apr; 11(2):649-661. PubMed ID: 38093506
[TBL] [Abstract][Full Text] [Related]
13. Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety.
Elkammash A; Tam SSC; Yogarajah G; You J
Cureus; 2023 Feb; 15(2):e35030. PubMed ID: 36938226
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
Anker SD; Butler J; Filippatos GS; Jamal W; Salsali A; Schnee J; Kimura K; Zeller C; George J; Brueckmann M; Zannad F; Packer M;
Eur J Heart Fail; 2019 Oct; 21(10):1279-1287. PubMed ID: 31523904
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.
Salah HM; Pandey A; Soloveva A; Abdelmalek MF; Diehl AM; Moylan CA; Wegermann K; Rao VN; Hernandez AF; Tedford RJ; Parikh KS; Mentz RJ; McGarrah RW; Fudim M
JACC Basic Transl Sci; 2021 Nov; 6(11):918-932. PubMed ID: 34869957
[TBL] [Abstract][Full Text] [Related]
16. Renal Dysfunction and Heart Failure with Preserved Ejection Fraction.
Ananthram MG; Gottlieb SS
Heart Fail Clin; 2021 Jul; 17(3):357-367. PubMed ID: 34051968
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fraction.
Gonzalez J; Bates BA; Setoguchi S; Gerhard T; Dave CV
Cardiovasc Diabetol; 2023 Mar; 22(1):54. PubMed ID: 36899387
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease.
Bonacchi G; Rossi VA; Garofalo M; Mollace R; Uccello G; Pieragnoli P; Checchi L; Perrotta L; Voltolini L; Ricciardi G; Beltrami M
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790943
[TBL] [Abstract][Full Text] [Related]
19. A novel mouse model of heart failure with preserved ejection fraction after chronic kidney disease induced by retinol through JAK/STAT pathway.
Liu B; Shalamu A; Pei Z; Liu L; Wei Z; Qu Y; Song S; Luo W; Dong Z; Weng X; Ge J
Int J Biol Sci; 2023; 19(12):3661-3677. PubMed ID: 37564202
[TBL] [Abstract][Full Text] [Related]
20. Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis.
Treewaree S; Kulthamrongsri N; Owattanapanich W; Krittayaphong R
Front Cardiovasc Med; 2023; 10():1046194. PubMed ID: 36824458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
